Advances in glucocorticoid-induced osteoporosis
Current Rheumatology Reports, ISSN: 1523-3774, Vol: 13, Issue: 3, Page: 233-240
2011
- 145Citations
- 90Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations145
- Citation Indexes143
- 143
- CrossRef67
- Policy Citations2
- 2
- Captures90
- Readers90
- 90
Article Description
Glucocorticoid-induced osteoporosis (GIOP) is one of the most important side effects of glucocorticoid use, as it leads to an increased risk of fractures. Recently, many published studies have focused on the cellular and molecular mechanisms of bone metabolism, the pathophysiology of GIOP, and the intervention options to prevent GIOP. In this review, recent advances in GIOP are summarized, particularly recent progress in our understanding of the mechanisms of GIOP resulting in improved insight that might result in the development of new treatment options in the near future. © 2011 The Author(s).
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79957526871&origin=inward; http://dx.doi.org/10.1007/s11926-011-0173-y; http://www.ncbi.nlm.nih.gov/pubmed/21365209; http://link.springer.com/10.1007/s11926-011-0173-y; https://dx.doi.org/10.1007/s11926-011-0173-y; https://link.springer.com/article/10.1007/s11926-011-0173-y; https://link.springer.com/content/pdf/10.1007%2Fs11926-011-0173-y.pdf; http://europepmc.org/abstract/med/21365209; http://europepmc.org/articles/PMC3092927; http://link.springer.com/article/10.1007%2Fs11926-011-0173-y
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know